They are not FDA-approved but are produced using pharmaceutical-grade ingredients and are tested for quality and sterility
Citations [1] Mikus D, Sikiric P, Seiwerth S, Petricevic A, Aralica G, Druzijancic N, Rucman R, Petek M, Pigac B, Perovic D, Kolombo M, Kokic N, Mikus S, Duplancic B, Fattorini I, Turkovic B, Rotkvic I, Mise S, Prkacin I, Konjevoda P, Stambuk N, Anic T
The SURPASS-2 trial showed tirzepatide 15 mg reduced HbA1c by 2.46 percentage points versus 1.86 for semaglutide 1 mg a clinically meaningful difference for patients managing diabetes
A number of studies support the use of GLP-1 for weight loss